Effects of sodium nitroprusside-induced controlled hypotension on pancreatic function assessed by pancreatitis-associated protein in patients undergoing radical prostatectomy

European Journal of Anaesthesiology

Volumn 19, Issue 8, 2002, Pages 609-613

  Piper, S N ^a   Suttner, S W ^a   Maleck, W H ^a   Kumle, B ^a   Haisch, G ^a   Boldt, J ^a  

^a KLINIKUM LUDWIGSHAFEN   (Germany)

Author keywords

Anaesthesia and analgesia, hypotension, controlled; Pancreatic function tests; Vasodilator agents, nitroprusside

Indexed keywords

ANESTHETIC AGENT; ATRACURIUM; CYCLIC GMP; FENTANYL; HEMOGLOBIN; ISOFLURANE; LORAZEPAM; NITROPRUSSIDE SODIUM; NITROUS OXIDE; PANCREAS ENZYME; THIOPENTAL; TRIACYLGLYCEROL LIPASE; BIOLOGICAL MARKER; LECTIN; PANCREATITIS ASSOCIATED PROTEIN; PANCREATITIS-ASSOCIATED PROTEIN; TUMOR ANTIGEN; TUMOR MARKER; VASODILATOR AGENT;

ADULT; AGED; ARTICLE; BLEEDING; BLOOD PRESSURE; BLOOD TRANSFUSION; CLINICAL ARTICLE; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; ENZYME ANALYSIS; GENERAL ANESTHESIA; HUMAN; INDUCED HYPOTENSION; INTRAOPERATIVE PERIOD; MALE; PANCREAS FUNCTION TEST; PROSTATE SURGERY; PROSTATECTOMY; RANDOMIZED CONTROLLED TRIAL; BLOOD; DRUG EFFECT; METHODOLOGY; MIDDLE AGED; PANCREAS; PHYSIOLOGY;

AGED; ANTIGENS, NEOPLASM; BIOLOGICAL MARKERS; HUMANS; HYPOTENSION, CONTROLLED; LECTINS, C-TYPE; LIPASE; MALE; MIDDLE AGED; NITROPRUSSIDE; PANCREAS; PROSTATECTOMY; TUMOR MARKERS, BIOLOGICAL; VASODILATOR AGENTS;

EID: 0036023271     PISSN: 02650215     EISSN: None     Source Type: Journal    
DOI: 10.1097/00003643-200208000-00012     Document Type: Article

References (28)

1. Sodium nitroprusside induced hypotension: Haemodynamic response and dose requirements during propofol or halothane anaesthesia
2. Esmolol is more effective than sodium nitroprusside in reducing blood loss during orthognathic surgery
3. A comparison of labetalol and nitroprusside for inducing hypotension during major surgery
4. Acute normovolaemic haemodilution vs controlled hypotension for reducing the use of allogenic blood in patients undergoing radical prostatectomy
5. Effects of hemodilution during controlled hypotension on hepatic, renal, and pancreatic function in humans
6. Induced hypotension
7. The role of ischemia in acute pancreatitis: Studies with an isolated perfused canine pancreas
8. Pancreatitis-associated protein protects the lung from leukocyte-induced injury
9. Pancreatitis-associated protein is upregulated in mouse pancreas during acute pancreatitis
10. Die kontrollierte hypotension [induced hypotension]
11. Evaluating tests for acute pancreatitis
12. An additional secretory protein in the rat pancreas
13. Pancreatitis-associated protein: A putative marker for pancreas graft rejection
14. Characterization of a rat pancreatic secretory protein associated with pancreatitis
15. Clinical value of pancreatic-associated protein in acute pancreatitis
16. Serum levels of pancreatitis-associated protein as indicators of the course of acute pancreatitis
17. Rat pancreatitis-associated protein is expressed in relation to severity of experimental pancreatitis
18. A novel exocrine protein associated with pancreas transplantation in humans
19. Immunocytochemical localization of pancreatitis-associated protein in human small intestine
20. Pancreatitis-associated protein in patients with celiac disease: Serum levels and immunocytochemical localization in small intestine
21. Pancreatitis after cardiac surgery. A morphologic study
22. Acute pancreatitis after cardiopulmonary bypass
23. Effects of ischemia on the human pancreas
24. Abdominal complications after cardiac surgery
25. Susceptibility of the pancreas to ischemic injury in shock
26. Anstieg der interleukin-6-plasmakonzentrationen nach hypotensiver anäthesie mit nitroprussidnatrium
27. Advances in the laboratory diagnostics of acute pancreatitis
28. Increased serum pancreatitis associated protein (PAP) concentration after alcohol consumption: Further evidence for regular subclinical pancreatic disease after heavy drinking?